After the type II collagen (CII)-induced arthritis (CIA) model was established, the researchers aimed to determine the protective effect of higenamine on collagen-induced arthritis through HO-1 and PI3K/Akt/Nrf-2 signaling pathways. The gene discussed is AKT1; the disease is arthritic joint disease.